A metabolic mechanism for cardiac K+ channel remodelling

Clinical and Experimental Pharmacology & Physiology
George J Rozanski, Zhi Xu

Abstract

1. Electrical remodelling of the ventricle is a common pathogenic feature of cardiovascular disease states that lead to heart failure. Experimental data suggest this change in electrophysiological phenotype is largely due to downregulation of K(+) channels involved in repolarization of the action potential. 2. Voltage-clamp studies of the transient outward current (I(to)) in diabetic cardiomyopathy support a metabolic mechanism for K(+) channel downregulation. In particular, I(to) density is significantly increased in diabetic rat isolated ventricular myocytes treated in vitro with insulin or agents that activate pyruvate dehydrogenase. Recent data suggest this mechanism is not limited to diabetic conditions, because metabolic stimuli that upregulate I(to) in diabetic rat myocytes act similarly in non- diabetic models of heart failure. 3. Depressed I(to) channel activity is also reversed by experimental conditions that increase myocyte levels of reduced glutathione, indicating that oxidative stress is involved in electrical remodelling. Moreover, upregulation of I(to) density by activators of glucose utilization is blocked by inhibitors of glutathione metabolism, supporting the premise that there is a functional link between gl...Continue Reading

References

Oct 22, 1990·Biochimica Et Biophysica Acta·N L ParinandiH H Schmid
May 22, 1990·The American Journal of Cardiology·J Kjekshus
Jan 1, 1990·Canadian Journal of Physiology and Pharmacology·P J O'BrienP W Armstrong
Jan 1, 1987·Free Radical Research Communications·R H BurdonC Rice-Evans
Nov 1, 1989·Metabolism: Clinical and Experimental·P W Stacpoole
Jan 1, 1995·Methods in Enzymology·A Meister
Feb 1, 1995·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·S Abdel-aleemJ E Lowe
Jan 1, 1995·Journal of Molecular and Cellular Cardiology·B RodriguesJ H McNeill
May 1, 1993·Journal of Molecular and Cellular Cardiology·C T LeA van der Laarse
Feb 1, 1994·Metabolism: Clinical and Experimental·G PaolissoF D'Onofrio
Mar 10, 1994·The American Journal of Cardiology·M O JeroudiR Bolli
Dec 22, 1993·Molecular and Cellular Biochemistry·P K SingalT P Thomas
May 26, 1993·Molecular and Cellular Biochemistry·M P Rigobello, A Bindoli
Sep 1, 1995·Journal of Molecular and Cellular Cardiology·M B MarcengillJ A Watts
Feb 1, 1997·Journal of Molecular and Cellular Cardiology·G J RozanskiI H Zucker
Jun 6, 1998·Cardiovascular Research·M Näbauer, S Kääb
Aug 5, 1998·The American Journal of Physiology·J I Kourie
Aug 26, 1998·Progress in Cardiovascular Diseases·M A Konstam, W J Remme
Oct 26, 1999·Cardiovascular Research·G F Tomaselli, E Marbán
Jul 11, 2000·Journal of Molecular and Cellular Cardiology·D R Van Wagoner, J M Nerbonne
Nov 18, 2000·Journal of Cardiovascular Electrophysiology·B HuangN El-Sherif

❮ Previous
Next ❯

Citations

Jun 1, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Philip B AdamsonKathryn A Yamada
Mar 8, 2003·Journal of Molecular and Cellular Cardiology·Gavin Y OuditPeter H Backx
Mar 30, 2006·The Journal of Biological Chemistry·Jun WengMing Zhou
Jun 3, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Xun LiGeorge J Rozanski
Apr 19, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Sayaka KurokawaTohru Izumi
Jul 22, 2009·Journal of Molecular and Cellular Cardiology·Noriko Niwa, Jeanne M Nerbonne
Sep 9, 2006·Endocrinology and Metabolism Clinics of North America·Gregg C Fonarow, Preethi Srikanthan
Sep 9, 2006·Endocrinology and Metabolism Clinics of North America·David A CesarioKalyanam Shivkumar
Aug 28, 2004·The Medical Clinics of North America·Preethi Srikanthan, Willa Hsueh
May 17, 2008·Journal of Molecular and Cellular Cardiology·Céline MarionneauJeanne M Nerbonne
Apr 19, 2003·Circulation Research·Masayasu Hiraoka
Nov 13, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Xun LiGeorge J Rozanski
Feb 13, 2007·American Journal of Physiology. Heart and Circulatory Physiology·M Kobayashi-MiuraJ Yodoi
May 27, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Sayaka KurokawaJunya Ako
Sep 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jürgen Borlak, Thomas Thum
May 11, 2002·American Journal of Physiology. Heart and Circulatory Physiology·George J Rozanski, Zhi Xu
May 6, 2008·Journal of Molecular and Cellular Cardiology·Huixu LiangGeorge J Rozanski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

© 2022 Meta ULC. All rights reserved